Abstract
Calcinosis cutis, or insoluble calcium salt deposition in the skin and subcutaneous tissue, results from local or systemic insults which disturb the factors regulating calcium. The condition is classified into four subtypes based on the presumed mechanism of calcium deposition: dystrophic, metastatic, iatrogenic, and idiopathic. This chapter expands on the subtype of calcification most commonly seen in renal disease: metastatic calcification.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Nassim JR, Connolly CK. Treatment of calcinosis universalis with aluminum hydroxide. Arch Dis Child. 1970;45:118–21.
Park YM, Lee SJ, Kang H, Cho SH. Large subcutaneous calcification in systemic lupus erythematosus: treatment with oral aluminum hydroxide administration followed by surgical excision. J Korean Med Sci. 1999;14:589–92.
Cukierman T, Elinav E, Korem M, Chajek-Shaul T. Low dose warfarin treatment for calcinosis in patients with systemic sclerosis. Ann Rheum Dis. 2004;63:1341–3.
Lassoued K, Saiag P, Anglade MC, Roujeau JC, Touraine RL. Failure of warfarin in treatment of calcinosis universalis. Am J Med. 1988;84:795–6.
Valdatta L, Buoro M, Thione A, et al. Idiopathic circumscripta calcinosis cutis of the knee. Dermatol Surg. 2003;29:1222–4.
Wang WJ, Lo WL, Wong CK. Calcinosis cutis in juvenile dermatomyositis: remarkable response to aluminum hydroxide therapy. Arch Dermatol. 1988;124:1721–2.
Sparsa A, Lesaux N, Kessler E, Bonnetblanc JM, Blaise S, Lebrun-Ly V, et al. Treatment of cutaneous calcinosis in CREST syndrome by extracorporeal shock wave lithotripsy. J Am Acad Dermatol. 2005;53:263–5.
Smith LH, Drach G, Hall P, Lingeman J, Preminger G, Resnick MI, Segura JW. National High Blood Pressure Education Program (NHBPEP) review paper on complications of shock wave lithotripsy for urinary calculi. Am J Med. 1991;91(6):635.
Robertson LP, Marshall RW, Hickling P. Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline. Ann Rheum Dis. 2003;62:267–9.
Ruiz-Genao DP, Rios-Buceta L, Herrero L, Fraga J, Aragues M, Garcia-Diez A. Massive scrotal calcinosis. Dermatol Surg. 2002;28:745–7.
Block GA. Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. Clin Nephrol. 2000;54:318–24.
Mukamel M, Horev G, Mimouni M. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr. 2001;138:763–6.
Rabens SF, Bethune JE. Disodium etidronate therapy for dystrophic cutaneous calcification. Arch Dermatol. 1975;111:357–61.
Abdallah-Lotf M, Grasland A, Vinceneux P, Sigal-Grinberg M. Regression of cutis calcinosis with diltiazem in adult dermatomyositis. Eur J Dermatol. 2005;15:102–4.
Ichiki Y, Akiyama T, Shimozawa N, Suzuki Y, Kondo N, Kitajima Y. An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem. Br J Dermatol. 2001;144:894–7.
Vayssairat M, Hidouche D, Abdoucheli-Baudot N, Gaitz JP. Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression? Ann Rheum Dis. 1998;57:252–4.
Chan AYK, Li E. Electric shock wave lithotripsy (ESWL) as a pain control measure in dermatomyositis with calcinosis cutis—old method, new discovery. Clin Rheumatol. 2005;24:172–3.
Wu JJ, Metz BJ. Calcinosis cutis of juvenile dermatomyositis treated with incision and drainage. Dermatol Surg. 2008;34:575–7.
Cousins MA, Jones DB, Whyte MP, Monafo WW. Surgical management of calcinosis cutis universalis in systemic lupus erythematosus. Arthritis Rheum. 1997;40:570–2.
Saddic N, Mille JJ, Miller F, Clarke JT. Surgical debridement of painful fingertip calcinosis cutis in CREST syndrome. Arch Dermatol. 2009;145:212–3.
Bottomley WW, Goodfield MJD, Sheehan-Dare RA. Digital calcification in systemic sclerosis: effective treatment with good tissue preservation using the carbon dioxide laser. Br J Dermatol. 1996;135:302–4.
Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E. Calcinosis cutis: part II. Treatment options. J Am Acad Dermatol. 2011;65:15–22. quiz 23–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Christman, M.P., Kroshinsky, D. (2015). Calcinosis Cutis. In: Nunley, J., Lerma, E. (eds) Dermatological Manifestations of Kidney Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2395-3_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2395-3_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2394-6
Online ISBN: 978-1-4939-2395-3
eBook Packages: MedicineMedicine (R0)